JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

Connected Transaction / Continuing Connected Transaction

Connected Transaction / Continuing Connected Transaction

NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2024

NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2024

NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024

NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024

Form of Proxy for the First H Share Class Meeting of 2024

Form of Proxy for the First H Share Class Meeting of 2024

Form of Proxy for the First Extraordinary General Meeting of 2024

Form of Proxy for the First Extraordinary General Meeting of 2024

New Arrangements on Dissemination of Corporate Communications

New Arrangements on Dissemination of Corporate Communications

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top